Filing Details
- Accession Number:
- 0001209191-18-004062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-17 17:58:30
- Reporting Period:
- 2018-01-12
- Accepted Time:
- 2018-01-17 17:58:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408920 | T Joseph Kennedy | C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2018-01-12 | 9,587 | $4.29 | 41,519 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2018-01-16 | 10,000 | $4.13 | 31,519 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2018-01-17 | 31,519 | $4.03 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sales made pursuant to a 10b5-1 trading plan dated December 9, 2016.
- The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.27 to $4.30, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.10 to $4.315, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.975 to $4.12, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price
- Please see the section titled "Remarks" below for additional information.
Billionaire Hedge Funds
